You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Freund's Adjuvant

Showing 1 - 25 of 4,572
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

Active, not recruiting
  • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Incomplete Freund's Adjuvant
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 12, 2022

Melanoma (Skin) Trial in Philadelphia, Houston, Charlottesville (incomplete Freund's adjuvant, melanoma helper peptide vaccine,

Completed
Has Results
  • Melanoma (Skin)
  • incomplete Freund's adjuvant
  • +4 more
  • Philadelphia, Pennsylvania
  • +2 more
Mar 25, 2021

Multiple Sclerosis Trial in San Diego (NeuroVax, IFA Incomplete Freund's Adjuvant)

Unknown status
  • Multiple Sclerosis
  • NeuroVax
  • IFA Incomplete Freund's Adjuvant
  • San Diego, California
    CRO
Mar 9, 2020

Melanoma (Skin) Trial in Charlottesville (biological, drug, procedure)

Completed
  • Melanoma (Skin)
  • incomplete Freund's adjuvant
  • +6 more
  • Charlottesville, Virginia
    University of Virginia Cancer Center
Mar 26, 2020

Multiple Sclerosis Trial in San Diego (NeuroVax, IFA Incomplete Freund's Adjuvant)

Not yet recruiting
  • Multiple Sclerosis
  • NeuroVax
  • IFA Incomplete Freund's Adjuvant
  • San Diego, California
    CRO
Mar 30, 2020

Breast Cancer Trial in Philadelphia (incomplete Freund's adjuvant, sargramostim, telomerase: 540-548 peptide vaccine)

Completed
  • Breast Cancer
  • incomplete Freund's adjuvant
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 3, 2020

Prostate Cancer Trial (PSA prostate cancer vaccine, incomplete Freund's adjuvant)

Completed
  • Prostate Cancer
  • PSA prostate cancer vaccine
  • incomplete Freund's adjuvant
  • (no location specified)
Oct 31, 2019

Rheumatoid Arthritis Trial ("apigenin" and "glycyrrhizin", "glycyrrhizin" and "boswellic acid", "")

Not yet recruiting
  • Rheumatoid Arthritis
  • "apigenin" and "glycyrrhizin"
  • +2 more
  • (no location specified)
Mar 27, 2023

Immune Response Trial in Oxford (Keyhole-Limpet Hemocyanin, Saline, Montanide ISA 51 VG)

Recruiting
  • Immune Response
  • Keyhole-Limpet Hemocyanin
  • +3 more
  • Oxford, United Kingdom
    NIHR Oxford Experimental Medicine Clinical Research Facility
May 16, 2023

Triple Negative Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (P10s-PADRE with MONTANIDE™ ISA 51 VG +

Active, not recruiting
  • Triple Negative Breast Cancer
  • Breast Neoplasms
  • P10s-PADRE with MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Paclitaxel
  • Doxorubicin + Cyclophosphamide + Paclitaxel
  • Fayetteville, Arkansas
  • +1 more
Aug 18, 2022

Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin +

Completed
  • Breast Cancer
  • Breast Neoplasms
  • Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Docetaxel (or Paclitaxel)
  • Fayetteville, Arkansas
  • +1 more
Jan 26, 2023

HIV Trial (HIV-1 Immunogen, Structured Treatment Interruption)

Withdrawn
  • HIV Infections
  • HIV-1 Immunogen
  • Structured Treatment Interruption
  • (no location specified)
Oct 28, 2021

Secondary Progress Multiple Sclerosis, Multiple Sclerosis Trial in San Diego (NeuroVax, IFA Placebo)

Recruiting
  • Secondary Progress Multiple Sclerosis
  • Multiple Sclerosis
  • NeuroVax
  • IFA Placebo
  • San Diego, California
    CRO
Mar 9, 2020

Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma Trial in United States

Recruiting
  • Advanced Colorectal Carcinoma
  • +42 more
  • Duarte, California
  • +9 more
Jan 21, 2023

HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), HIV-1 Immunogen)

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • HIV-1 Immunogen
  • Los Angeles, California
  • +16 more
Oct 28, 2021

Breast Cancer Trial in Scottsdale, Jacksonville, Rochester (CpG oligodeoxynucleotide, HER-2/neu peptide vaccine, MUC-1 peptide

Completed
  • Breast Cancer
  • CpG oligodeoxynucleotide
  • +6 more
  • Scottsdale, Arizona
  • +2 more
Oct 29, 2018

Juvenile Idiopathic Arthritis Trial in Cairo (dietary supplement, other, drug)

Recruiting
  • Juvenile Idiopathic Arthritis
  • Coenzyme Q10
  • +2 more
  • Cairo, Egypt
    Pediatric Allergy, Immunology, Rheumatology Clinic, Children's H
May 27, 2023

Soft Tissue Sarcoma Trial in France (Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior

Not yet recruiting
  • Soft Tissue Sarcoma
  • Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior to surgery.
  • Patient will undergo surgery before receive the adjuvant hypofractionated radiation therapy (40 Gy in 15 fractions).
  • Bordeaux, France
  • +10 more
Aug 28, 2023

Endometrial Carcinoma Trial in Sohag (Paclitaxel/epirubcin/carboplatin, Paclitaxel/carboplatin)

Not yet recruiting
  • Endometrial Carcinoma
  • Sohag, Egypt
    Sohag university Hospital
Oct 25, 2023

Shigellosis, Bacillary Dysentery Trial in Leiden (2.5 µg InvaplexAR-Detox, 10 µg InvaplexAR-Detox, 0.1 µg of dmLT)

Not yet recruiting
  • Shigellosis
  • Bacillary Dysentery
  • 2.5 μg InvaplexAR-Detox
  • +3 more
  • Leiden, Netherlands
    Leiden University Medical Center
Jul 26, 2023

Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

Recruiting
  • Glioblastoma, IDH-wildtype
  • MGMT-Methylated Glioblastoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Oct 18, 2023

Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine

Recruiting
  • Hepatitis B
  • GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
  • +4 more
  • Cambridge, United Kingdom
    GSK Investigational Site
Jan 12, 2023

Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • (no location specified)
Nov 15, 2023

Brain Metastases Trial (Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Stereotactic Radiation Therapy)

Not yet recruiting
  • Brain Metastases
  • Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)
  • Stereotactic Radiation Therapy
  • (no location specified)
Jun 2, 2023

Periodontitis, Obesity Trial in Bauru (antimicrobial photodynamic therapy (aPDT), Control)

Recruiting
  • Periodontitis
  • Obesity
  • antimicrobial photodynamic therapy (aPDT)
  • Control
  • Bauru, São Paulo, Brazil
    Bauru School of Dentistry
Oct 9, 2023